By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. The Power Of Missile Defense Please click here for a chart of RTX Corporation stock (RTX). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Important Data Ahead Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the dip in
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Chinese Market Breaks Negative Pattern Please click here for a chart of Mainland China ETF (ASHR). Note the following: In prior Morning Capsules, we shared with you details of China’s stimulus program. Prior
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Spending Disappointment Please click here for a chart of Super Micro Computer stock (SMCI). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of SMCI
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Growing Optimism Please click here for a chart of Micron stock (MU). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of MU stock is
By Nigam Arora & Dr. Natasha Arora Do you want to know where to make the next fortune in AI? Listen to this interview of Nigam Arora by Oliver Renick of Schwab Network. Click here to watch the interview. To take a free 30-day trial to paid services to gain access to more
By Nigam Arora & Dr. Natasha Arora Better Than Gold Standard In a Phase 3 study, Summit Therapeutics Inc’s (SMMT) drug showed a statistically significant 5.3 months of improvement in progression free survival versus Keytruda in treatment of PD-L1- positive advanced non-small cell lung cancer. Keytruda from MRK is the gold standard.
By Nigam Arora & Dr. Natasha Arora Making Money From Buyouts When a company gets bought out, it is often at a higher price, generating profits for shareholders. By consistently investing in companies that get bought out, investors can make a fortune over the long term. The Arora Report record is unrivaled.
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. AI Exuberance Please click here for a chart of Quanta Services stocks (PWR). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of PWR stock